Results 361 to 367 of about 4,080,709 (367)

Systemic Therapy for Metastatic Renal-Cell Carcinoma.

New England Journal of Medicine, 2017
Until recently, there was a dearth of effective systemic therapies for kidney cancer. The incidence of the disease steadily increased from 1975 through 2008 and leveled off after 2008.1-3 Currently, it is among the 10 most frequently diagnosed cancers in
T. Choueiri, R. Motzer
semanticscholar   +1 more source

Renal cell carcinoma.

Bulletin of Tufts New England Medical Center, 1956
M. Thurnher, Thomas Putz, A. Rahm, Hubert Gander, R. Ramoner, G. Bartsch, Lorenz Hltl, C. Falkensammer   +7 more
semanticscholar   +1 more source

Clinical epidemiology of cardiovascular disease in chronic renal disease.

American Journal of Kidney Diseases, 1998
R. Foley, P. Parfrey, M. Sarnak
semanticscholar   +1 more source

Macrophages: versatile players in renal inflammation and fibrosis

Nature Reviews Nephrology, 2019
P. Tang, D. Nikolic-Paterson, H. Lan
semanticscholar   +1 more source

Renal, metabolic and cardiovascular considerations of SGLT2 inhibition

Nature Reviews Nephrology, 2017
R. DeFronzo, L. Norton, M. Abdul-Ghani
semanticscholar   +1 more source

The epidemiology of renal cell carcinoma.

European Urology, 2011
B. Ljungberg, S. Campbell, H. Choi, D. Jacqmin, J. E. Lee, S. Weikert, L. Kiemeney   +6 more
semanticscholar   +1 more source

Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease

Nature Network Boston, 2015
M. T. Grande, B. Sanchez-Laorden, Cristina López-Blau, Cristina, A. D. Frutos, A. Boutet, M. Arévalo, R. G. Rowe, Stephen, J. Weiss, J. López-Novoa, M. A. Nieto   +11 more
semanticscholar   +1 more source